Compounds of Formula I,are provided. In Formula I, M is Pd or Pt; each of X1 to X14 is C or N; one of Z1 and Z2 is C and the other is N; Y is selected from O, S, Se, N*R, CRR′, SiRR′, or GeRR′; K1 is a direct bond, O, or S; each R, R′, RA, RB, RC, and RD is independently
hydrogen or a
substituent; at least one of R, R′, RA, RB, RC, or RD is a
substituent R*; and (i) R* comprises a 5-membered or 6-membered heterocyclic ring, or (ii) R* comprises Formula Ia:Formula Ia;wherein each of RY and RZ independently represents mono to the maximum allowable substitution, or no substitution;R1, R2, R3, R4, RY and RZ is independently
hydrogen or a
substituent selected from the group consisting of
deuterium,
halogen,
alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl,
aryl, heteroaryl, acyl,
carboxylic acid,
ether, ester,
nitrile, isonitrile,
sulfanyl, sulfinyl,
sulfonyl, phosphino, boryl, selenyl, and combinations thereof;wherein at least one of R1, R2, R3, and R4 is not
hydrogen. Formulations, OLEDs, and
consumer products including the compound are also provided.